PCSK9 and Hypercholesterolemia: Proprotein convertase subtilisin/kexin type 9 (PCSK9), mainly synthesized by hepatocytes and one of the key enzymes in lipid transport, was correlated with an expanded risk for hypercholesterolemia and coronary artery disease (1).